世界のウイルス性結膜炎薬市場2020年:企業別、地域別、種類・用途別

【英語タイトル】Global Viral Conjunctivitis Drugs Market 2020 by Company, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが出版した調査資料(GIR20SP04770)・商品コード:GIR20SP04770
・発行会社(調査会社):GlobalInfoResearch
・発行日:2020年9月18日(※2024年版があります。お問い合わせください)
・ページ数:103
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医療、製薬、バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは、ウイルス性結膜炎薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。ウイルス性結膜炎薬の種類別市場規模(FST-100、APD-209)、用途別市場規模(病院、ASC)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。
・市場概要
・企業情報(販売量、市場シェア、製品概要、SWOT分析):Adenovir Pharma、NicOx、Takeda、Allergan、Panoptes Pharma、NanoViricides、Novartis、NovaBay Pharmaceuticals
・地域別グローバル市場分析 2015年-2020年
・ウイルス性結膜炎薬の北米市場(アメリカ、カナダ、メキシコ)
・ウイルス性結膜炎薬のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・ウイルス性結膜炎薬のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・ウイルス性結膜炎薬の南米市場(ブラジル、アルゼンチン)
・ウイルス性結膜炎薬の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:FST-100、APD-209
・用途別分析:病院、ASC
・地域別市場規模予測 2021年-2025年
・調査の結果・結論
【レポートの概要】

Market Overview
The global Viral Conjunctivitis Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Viral Conjunctivitis Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Viral Conjunctivitis Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Viral Conjunctivitis Drugs market has been segmented into:
FST-100
APD-209

By Application, Viral Conjunctivitis Drugs has been segmented into:
Hospitals
ASCs

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Viral Conjunctivitis Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Viral Conjunctivitis Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Viral Conjunctivitis Drugs market.

The report offers in-depth assessment of the growth and other aspects of the Viral Conjunctivitis Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Viral Conjunctivitis Drugs Market Share Analysis
Viral Conjunctivitis Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Viral Conjunctivitis Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Viral Conjunctivitis Drugs sales, revenue and market share for each player covered in this report.

The major players covered in Viral Conjunctivitis Drugs are:
Adenovir Pharma
NicOx
Takeda
Allergan
Panoptes Pharma
NanoViricides
Novartis
NovaBay Pharmaceuticals

【レポートの目次】

Table of Contents

1 Viral Conjunctivitis Drugs Market Overview
1.1 Product Overview and Scope of Viral Conjunctivitis Drugs
1.2 Classification of Viral Conjunctivitis Drugs by Type
1.2.1 Global Viral Conjunctivitis Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Viral Conjunctivitis Drugs Revenue Market Share by Type in 2019
1.2.3 FST-100
1.2.4 APD-209
1.3 Global Viral Conjunctivitis Drugs Market by Application
1.3.1 Overview: Global Viral Conjunctivitis Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 ASCs
1.4 Global Viral Conjunctivitis Drugs Market by Regions
1.4.1 Global Viral Conjunctivitis Drugs Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Viral Conjunctivitis Drugs (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Viral Conjunctivitis Drugs Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Viral Conjunctivitis Drugs Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Viral Conjunctivitis Drugs Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Viral Conjunctivitis Drugs Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Viral Conjunctivitis Drugs Status and Prospect (2015-2025)
2 Company Profiles
2.1 Adenovir Pharma
2.1.1 Adenovir Pharma Details
2.1.2 Adenovir Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Adenovir Pharma SWOT Analysis
2.1.4 Adenovir Pharma Product and Services
2.1.5 Adenovir Pharma Viral Conjunctivitis Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.2 NicOx
2.2.1 NicOx Details
2.2.2 NicOx Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 NicOx SWOT Analysis
2.2.4 NicOx Product and Services
2.2.5 NicOx Viral Conjunctivitis Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.3 Takeda
2.3.1 Takeda Details
2.3.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Takeda SWOT Analysis
2.3.4 Takeda Product and Services
2.3.5 Takeda Viral Conjunctivitis Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.4 Allergan
2.4.1 Allergan Details
2.4.2 Allergan Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Allergan SWOT Analysis
2.4.4 Allergan Product and Services
2.4.5 Allergan Viral Conjunctivitis Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.5 Panoptes Pharma
2.5.1 Panoptes Pharma Details
2.5.2 Panoptes Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Panoptes Pharma SWOT Analysis
2.5.4 Panoptes Pharma Product and Services
2.5.5 Panoptes Pharma Viral Conjunctivitis Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.6 NanoViricides
2.6.1 NanoViricides Details
2.6.2 NanoViricides Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 NanoViricides SWOT Analysis
2.6.4 NanoViricides Product and Services
2.6.5 NanoViricides Viral Conjunctivitis Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.7 Novartis
2.7.1 Novartis Details
2.7.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Novartis SWOT Analysis
2.7.4 Novartis Product and Services
2.7.5 Novartis Viral Conjunctivitis Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.8 NovaBay Pharmaceuticals
2.8.1 NovaBay Pharmaceuticals Details
2.8.2 NovaBay Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 NovaBay Pharmaceuticals SWOT Analysis
2.8.4 NovaBay Pharmaceuticals Product and Services
2.8.5 NovaBay Pharmaceuticals Viral Conjunctivitis Drugs Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Viral Conjunctivitis Drugs Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Viral Conjunctivitis Drugs Players Market Share
3.2.2 Top 10 Viral Conjunctivitis Drugs Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Viral Conjunctivitis Drugs Revenue and Market Share by Regions
4.2 North America Viral Conjunctivitis Drugs Revenue and Growth Rate (2015-2020)
4.3 Europe Viral Conjunctivitis Drugs Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Viral Conjunctivitis Drugs Revenue and Growth Rate (2015-2020)
4.5 South America Viral Conjunctivitis Drugs Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Viral Conjunctivitis Drugs Revenue and Growth Rate (2015-2020)
5 North America Viral Conjunctivitis Drugs Revenue by Countries
5.1 North America Viral Conjunctivitis Drugs Revenue by Countries (2015-2020)
5.2 USA Viral Conjunctivitis Drugs Revenue and Growth Rate (2015-2020)
5.3 Canada Viral Conjunctivitis Drugs Revenue and Growth Rate (2015-2020)
5.4 Mexico Viral Conjunctivitis Drugs Revenue and Growth Rate (2015-2020)
6 Europe Viral Conjunctivitis Drugs Revenue by Countries
6.1 Europe Viral Conjunctivitis Drugs Revenue by Countries (2015-2020)
6.2 Germany Viral Conjunctivitis Drugs Revenue and Growth Rate (2015-2020)
6.3 UK Viral Conjunctivitis Drugs Revenue and Growth Rate (2015-2020)
6.4 France Viral Conjunctivitis Drugs Revenue and Growth Rate (2015-2020)
6.5 Russia Viral Conjunctivitis Drugs Revenue and Growth Rate (2015-2020)
6.6 Italy Viral Conjunctivitis Drugs Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Viral Conjunctivitis Drugs Revenue by Countries
7.1 Asia-Pacific Viral Conjunctivitis Drugs Revenue by Countries (2015-2020)
7.2 China Viral Conjunctivitis Drugs Revenue and Growth Rate (2015-2020)
7.3 Japan Viral Conjunctivitis Drugs Revenue and Growth Rate (2015-2020)
7.4 Korea Viral Conjunctivitis Drugs Revenue and Growth Rate (2015-2020)
7.5 India Viral Conjunctivitis Drugs Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Viral Conjunctivitis Drugs Revenue and Growth Rate (2015-2020)
8 South America Viral Conjunctivitis Drugs Revenue by Countries
8.1 South America Viral Conjunctivitis Drugs Revenue by Countries (2015-2020)
8.2 Brazil Viral Conjunctivitis Drugs Revenue and Growth Rate (2015-2020)
8.3 Argentina Viral Conjunctivitis Drugs Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Viral Conjunctivitis Drugs by Countries
9.1 Middle East & Africa Viral Conjunctivitis Drugs Revenue by Countries (2015-2020)
9.2 Saudi Arabia Viral Conjunctivitis Drugs Revenue and Growth Rate (2015-2020)
9.3 UAE Viral Conjunctivitis Drugs Revenue and Growth Rate (2015-2020)
9.4 Egypt Viral Conjunctivitis Drugs Revenue and Growth Rate (2015-2020)
9.5 South Africa Viral Conjunctivitis Drugs Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Viral Conjunctivitis Drugs Revenue and Market Share by Type (2015-2020)
10.2 Global Viral Conjunctivitis Drugs Market Forecast by Type (2019-2024)
10.3 FST-100 Revenue Growth Rate (2015-2025)
10.4 APD-209 Revenue Growth Rate (2015-2025)
11 Global Viral Conjunctivitis Drugs Market Segment by Application
11.1 Global Viral Conjunctivitis Drugs Revenue Market Share by Application (2015-2020)
11.2 Viral Conjunctivitis Drugs Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 ASCs Revenue Growth (2015-2020)
12 Global Viral Conjunctivitis Drugs Market Size Forecast (2021-2025)
12.1 Global Viral Conjunctivitis Drugs Market Size Forecast (2021-2025)
12.2 Global Viral Conjunctivitis Drugs Market Forecast by Regions (2021-2025)
12.3 North America Viral Conjunctivitis Drugs Revenue Market Forecast (2021-2025)
12.4 Europe Viral Conjunctivitis Drugs Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Viral Conjunctivitis Drugs Revenue Market Forecast (2021-2025)
12.6 South America Viral Conjunctivitis Drugs Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Viral Conjunctivitis Drugs Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Viral Conjunctivitis Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Viral Conjunctivitis Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Viral Conjunctivitis Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Viral Conjunctivitis Drugs Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Adenovir Pharma Corporate Information, Location and Competitors
Table 6. Adenovir Pharma Viral Conjunctivitis Drugs Major Business
Table 7. Adenovir Pharma Viral Conjunctivitis Drugs Total Revenue (USD Million) (2017-2018)
Table 8. Adenovir Pharma SWOT Analysis
Table 9. Adenovir Pharma Viral Conjunctivitis Drugs Product and Solutions
Table 10. Adenovir Pharma Viral Conjunctivitis Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. NicOx Corporate Information, Location and Competitors
Table 12. NicOx Viral Conjunctivitis Drugs Major Business
Table 13. NicOx Viral Conjunctivitis Drugs Total Revenue (USD Million) (2018-2019)
Table 14. NicOx SWOT Analysis
Table 15. NicOx Viral Conjunctivitis Drugs Product and Solutions
Table 16. NicOx Viral Conjunctivitis Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Takeda Corporate Information, Location and Competitors
Table 18. Takeda Viral Conjunctivitis Drugs Major Business
Table 19. Takeda Viral Conjunctivitis Drugs Total Revenue (USD Million) (2017-2018)
Table 20. Takeda SWOT Analysis
Table 21. Takeda Viral Conjunctivitis Drugs Product and Solutions
Table 22. Takeda Viral Conjunctivitis Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Allergan Corporate Information, Location and Competitors
Table 24. Allergan Viral Conjunctivitis Drugs Major Business
Table 25. Allergan Viral Conjunctivitis Drugs Total Revenue (USD Million) (2017-2018)
Table 26. Allergan SWOT Analysis
Table 27. Allergan Viral Conjunctivitis Drugs Product and Solutions
Table 28. Allergan Viral Conjunctivitis Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Panoptes Pharma Corporate Information, Location and Competitors
Table 30. Panoptes Pharma Viral Conjunctivitis Drugs Major Business
Table 31. Panoptes Pharma Viral Conjunctivitis Drugs Total Revenue (USD Million) (2017-2018)
Table 32. Panoptes Pharma SWOT Analysis
Table 33. Panoptes Pharma Viral Conjunctivitis Drugs Product and Solutions
Table 34. Panoptes Pharma Viral Conjunctivitis Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. NanoViricides Corporate Information, Location and Competitors
Table 36. NanoViricides Viral Conjunctivitis Drugs Major Business
Table 37. NanoViricides Viral Conjunctivitis Drugs Total Revenue (USD Million) (2017-2018)
Table 38. NanoViricides SWOT Analysis
Table 39. NanoViricides Viral Conjunctivitis Drugs Product and Solutions
Table 40. NanoViricides Viral Conjunctivitis Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Novartis Corporate Information, Location and Competitors
Table 42. Novartis Viral Conjunctivitis Drugs Major Business
Table 43. Novartis Viral Conjunctivitis Drugs Total Revenue (USD Million) (2017-2018)
Table 44. Novartis SWOT Analysis
Table 45. Novartis Viral Conjunctivitis Drugs Product and Solutions
Table 46. Novartis Viral Conjunctivitis Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. NovaBay Pharmaceuticals Corporate Information, Location and Competitors
Table 48. NovaBay Pharmaceuticals Viral Conjunctivitis Drugs Major Business
Table 49. NovaBay Pharmaceuticals Viral Conjunctivitis Drugs Total Revenue (USD Million) (2017-2018)
Table 50. NovaBay Pharmaceuticals SWOT Analysis
Table 51. NovaBay Pharmaceuticals Viral Conjunctivitis Drugs Product and Solutions
Table 52. NovaBay Pharmaceuticals Viral Conjunctivitis Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Global Viral Conjunctivitis Drugs Revenue (Million USD) by Players (2015-2020)
Table 54. Global Viral Conjunctivitis Drugs Revenue Share by Players (2015-2020)
Table 55. Global Viral Conjunctivitis Drugs Revenue (Million USD) by Regions (2015-2020)
Table 56. Global Viral Conjunctivitis Drugs Revenue Market Share by Regions (2015-2020)
Table 57. North America Viral Conjunctivitis Drugs Revenue by Countries (2015-2020)
Table 58. North America Viral Conjunctivitis Drugs Revenue Market Share by Countries (2015-2020)
Table 59. Europe Viral Conjunctivitis Drugs Revenue (Million USD) by Countries (2015-2020)
Table 60. Asia-Pacific Viral Conjunctivitis Drugs Revenue (Million USD) by Countries (2015-2020)
Table 61. South America Viral Conjunctivitis Drugs Revenue by Countries (2015-2020)
Table 62. South America Viral Conjunctivitis Drugs Revenue Market Share by Countries (2015-2020)
Table 63. Middle East and Africa Viral Conjunctivitis Drugs Revenue (Million USD) by Countries (2015-2020)
Table 64. Middle East and Africa Viral Conjunctivitis Drugs Revenue Market Share by Countries (2015-2020)
Table 65. Global Viral Conjunctivitis Drugs Revenue (Million USD) by Type (2015-2020)
Table 66. Global Viral Conjunctivitis Drugs Revenue Share by Type (2015-2020)
Table 67. Global Viral Conjunctivitis Drugs Revenue Forecast by Type (2021-2025)
Table 68. Global Viral Conjunctivitis Drugs Revenue by Application (2015-2020)
Table 69. Global Viral Conjunctivitis Drugs Revenue Share by Application (2015-2020)
Table 70. Global Viral Conjunctivitis Drugs Revenue Forecast by Application (2021-2025)
Table 71. Global Viral Conjunctivitis Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Viral Conjunctivitis Drugs Picture
Figure 2. Global Viral Conjunctivitis Drugs Revenue Market Share by Type in 2019
Figure 3. FST-100 Picture
Figure 4. APD-209 Picture
Figure 5. Viral Conjunctivitis Drugs Revenue Market Share by Application in 2019
Figure 6. Hospitals Picture
Figure 7. ASCs Picture
Figure 8. Global Viral Conjunctivitis Drugs Revenue (USD Million) and Growth Rate (2015-2025)
Figure 9. North America Viral Conjunctivitis Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 10. Europe Viral Conjunctivitis Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Asia-Pacific Viral Conjunctivitis Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. South America Viral Conjunctivitis Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Middle East and Africa Viral Conjunctivitis Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Global Viral Conjunctivitis Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Viral Conjunctivitis Drugs Revenue Share by Players in 2019
Figure 16. Global Top 5 Players Viral Conjunctivitis Drugs Revenue Market Share in 2019
Figure 17. Global Top 10 Players Viral Conjunctivitis Drugs Revenue Market Share in 2019
Figure 18. Key Players Market Share Trend
Figure 19. Global Viral Conjunctivitis Drugs Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 20. Global Viral Conjunctivitis Drugs Revenue Market Share by Regions (2015-2020)
Figure 21. Global Viral Conjunctivitis Drugs Revenue Market Share by Regions in 2018
Figure 22. North America Viral Conjunctivitis Drugs Revenue and Growth Rate (2015-2020)
Figure 23. Europe Viral Conjunctivitis Drugs Revenue and Growth Rate (2015-2020)
Figure 24. Asia-Pacific Viral Conjunctivitis Drugs Revenue and Growth Rate (2015-2020)
Figure 25. South America Viral Conjunctivitis Drugs Revenue and Growth Rate (2015-2020)
Figure 26. Middle East and Africa Viral Conjunctivitis Drugs Revenue and Growth Rate (2015-2020)
Figure 27. North America Viral Conjunctivitis Drugs Revenue Market Share by Countries (2015-2020)
Figure 28. North America Viral Conjunctivitis Drugs Revenue Market Share by Countries in 2019
Figure 29. USA Viral Conjunctivitis Drugs Revenue and Growth Rate (2015-2020)
Figure 30. Canada Viral Conjunctivitis Drugs Revenue and Growth Rate (2015-2020)
Figure 31. Mexico Viral Conjunctivitis Drugs Revenue and Growth Rate (2015-2020)
Figure 32. Europe Viral Conjunctivitis Drugs Revenue Market Share by Countries (2015-2020)
Figure 33. Europe Viral Conjunctivitis Drugs Revenue Market Share by Countries in 2019
Figure 34. Germany Viral Conjunctivitis Drugs Revenue and Growth Rate (2015-2020)
Figure 35. UK Viral Conjunctivitis Drugs Revenue and Growth Rate (2015-2020)
Figure 36. France Viral Conjunctivitis Drugs Revenue and Growth Rate (2015-2020)
Figure 37. Russia Viral Conjunctivitis Drugs Revenue and Growth Rate (2015-2020)
Figure 38. Italy Viral Conjunctivitis Drugs Revenue and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Viral Conjunctivitis Drugs Revenue Market Share by Countries (2015-2020)
Figure 40. Asia-Pacific Viral Conjunctivitis Drugs Revenue Market Share by Countries in 2019
Figure 41. China Viral Conjunctivitis Drugs Revenue and Growth Rate (2015-2020)
Figure 42. Japan Viral Conjunctivitis Drugs Revenue and Growth Rate (2015-2020)
Figure 43. Korea Viral Conjunctivitis Drugs Revenue and Growth Rate (2015-2020)
Figure 44. India Viral Conjunctivitis Drugs Revenue and Growth Rate (2015-2020)
Figure 45. Southeast Asia Viral Conjunctivitis Drugs Revenue and Growth Rate (2015-2020)
Figure 46. South America Viral Conjunctivitis Drugs Revenue Market Share by Countries (2015-2020)
Figure 47. South America Viral Conjunctivitis Drugs Revenue Market Share by Countries in 2019
Figure 48. Brazil Viral Conjunctivitis Drugs Revenue and Growth Rate (2015-2020)
Figure 49. Argentina Viral Conjunctivitis Drugs Revenue and Growth Rate (2015-2020)
Figure 50. Middle East and Africa Viral Conjunctivitis Drugs Revenue Market Share by Countries (2015-2020)
Figure 51. Middle East and Africa Viral Conjunctivitis Drugs Revenue Market Share by Countries in 2019
Figure 52. Saudi Arabia Viral Conjunctivitis Drugs Revenue and Growth Rate (2015-2020)
Figure 53. UAE Viral Conjunctivitis Drugs Revenue and Growth Rate (2015-2020)
Figure 54. Egypt Viral Conjunctivitis Drugs Revenue and Growth Rate (2015-2020)
Figure 55. South Africa Viral Conjunctivitis Drugs Revenue and Growth Rate (2015-2020)
Figure 56. Global Viral Conjunctivitis Drugs Revenue Share by Type (2015-2020)
Figure 57. Global Viral Conjunctivitis Drugs Revenue Share by Type in 2019
Figure 58. Global Viral Conjunctivitis Drugs Market Share Forecast by Type (2021-2025)
Figure 59. Global FST-100 Revenue Growth Rate (2015-2020)
Figure 60. Global APD-209 Revenue Growth Rate (2015-2020)
Figure 61. Global Viral Conjunctivitis Drugs Revenue Share by Application (2015-2020)
Figure 62. Global Viral Conjunctivitis Drugs Revenue Share by Application in 2019
Figure 63. Global Viral Conjunctivitis Drugs Market Share Forecast by Application (2021-2025)
Figure 64. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 65. Global ASCs Revenue Growth Rate (2015-2020)
Figure 66. Global Viral Conjunctivitis Drugs Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 67. Global Viral Conjunctivitis Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 68. Global Viral Conjunctivitis Drugs Revenue Market Share Forecast by Regions (2021-2025)
Figure 69. North America Viral Conjunctivitis Drugs Revenue Market Forecast (2021-2025)
Figure 70. Europe Viral Conjunctivitis Drugs Revenue Market Forecast (2021-2025)
Figure 71. Asia-Pacific Viral Conjunctivitis Drugs Revenue Market Forecast (2021-2025)
Figure 72. South America Viral Conjunctivitis Drugs Revenue Market Forecast (2021-2025)
Figure 73. Middle East and Africa Viral Conjunctivitis Drugs Revenue Market Forecast (2021-2025)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel


【掲載企業】

Adenovir Pharma、NicOx、Takeda、Allergan、Panoptes Pharma、NanoViricides、Novartis、NovaBay Pharmaceuticals

★調査レポート[世界のウイルス性結膜炎薬市場2020年:企業別、地域別、種類・用途別] (コード:GIR20SP04770)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のウイルス性結膜炎薬市場2020年:企業別、地域別、種類・用途別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆